Настройки

Укажите год
-

Небесная энциклопедия

Космические корабли и станции, автоматические КА и методы их проектирования, бортовые комплексы управления, системы и средства жизнеобеспечения, особенности технологии производства ракетно-космических систем

Подробнее
-

Мониторинг СМИ

Мониторинг СМИ и социальных сетей. Сканирование интернета, новостных сайтов, специализированных контентных площадок на базе мессенджеров. Гибкие настройки фильтров и первоначальных источников.

Подробнее

Форма поиска

Поддерживает ввод нескольких поисковых фраз (по одной на строку). При поиске обеспечивает поддержку морфологии русского и английского языка
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Ведите корректный номера.
Укажите год
Укажите год
Применить Всего найдено 22. Отображено 22.
13-06-2002 дата публикации

Use of creatine and/or creatine derivatives for treating typical disorders in women

Номер: US20020072541A1
Автор: Ivo Pischel, Helen Holland, Brigitta Schwartz, Andrea Huber, Ralf Jager
Принадлежит:

The invention relates to the use of creatine and/or creatine derivatives for treating typical disorders in women, for example PMS or dysmenorrhea, which involves the prophylactic of therapeutic use, in particular, of creatine monohydrate, creatine pyruvates, creatine ascorbates and creatine α-ketoglutarates as creatine derivatives in preferred daily doses of 0.1 g to 20 g. The invention also provides for the use of creatine or its derivatives as mixtures with a pyruvate, ascorbate or α-ketoglutarate. The creatine or its appropriate derivatives are not restricted to any particular form of application, which makes them all the more suitable for the many symptoms of typical female disorders.

Подробнее
Номер записи: 1
23-11-2006 дата публикации

Filler material for a beverage container

Номер: US20060263486A1
Автор: Ralf Jager, Martin Purpura, Reinhard Kroner
Принадлежит:

The subject of the present invention relates to a filler material for a container having at least one chamber which is situated in a beverage container under pressure and immediately after the opening of the beverage container is suitable for the admixture of the filler material into the beverage liquid surrounding it. The filler material itself is in granule form and is composed of the chief component a) in the form of a nutritional supplement and an effervescent component b). The component a), which should be present in the filler material in percentages between 35 and 98 wt.-%, can be non-prescription agents, vitamins, creatine derivatives, phospholipids, probiotics, minerals, unsaturated fatty acids and any mixtures thereof. The fillers can be put into beverage liquids with varying pH, since due to their dissolving ability and due to the targeted selection of appropriate effervescence and bursting components can be dissolved quickly and completely in the beverage liquid.

Подробнее
Номер записи: 2
22-12-2020 дата публикации

Method for increasing muscle mass and strength

Номер: US0010869843B2
Автор: Lorenzo De Ferra, Marvin Heuer, Scott Hagerman, Martin Purpura, Ralf Jager, DE FERRA LORENZO, HEUER MARVIN, HAGERMAN SCOTT, PURPURA MARTIN, JAGER RALF, De Ferra, Lorenzo, Heuer, Marvin, Hagerman, Scott, Purpura, Martin, Jager, Ralf
Принадлежит: CHEMI NUTRA, DE FERRA LORENZO, HEUER MARVIN, HAGERMAN SCOTT, PURPURA MARTIN, JAGER RALF, De Ferra Lorenzo, Heuer Marvin, Hagerman Scott, Purpura Martin, Jager Ralf

Phosphatidic acid is administered orally to increase muscle mass and strength in exercising mammals. Phosphatidic acid is administered orally to aging, bedridden or cachectic patients to improve nitrogen balance. The preferred form of phosphatidic acid for administration is phosphatidic acid-enriched lecithin. Creatine is co-administered orally to increase the muscle-building and strength effect. Other suggested additives include nutritional and herbal supplements, micronutrients and hormones.

Подробнее
Номер записи: 3
30-03-2021 дата публикации

Stabilization of beta-hydroxyisovaleric acid formulations in soft gel capsules

Номер: US0010959957B2
Автор: Martin Purpura, Ralf Jager, Jie Gu, Xiong Zheng, Iingwei Dai, Yaohua Zhang, PURPURA MARTIN, JAGER RALF, GU JIE, ZHENG XIONG, DAI IINGWEI, ZHANG YAOHUA, Purpura, Martin, Jager, Ralf, Gu, Jie, Zheng, Xiong, Dai, Iingwei, Zhang, Yaohua
Принадлежит: TSI Group Ltd., TSI GROUP LTD

The disclosed are shelf-stable beta-hydroxyisovaleric acid containing soft gel compositions and methods for making such compositions. In certain aspects, disclosed compositions comprise a plant-based capsule shell and a liquid formulation comprising beta-hydroxyisovaleric acid and at least one excipient, wherein the soft gel capsule is shelf-stable. In certain aspects, the excipient is selected from selected from choline salt, betaine, phosphatidylcholine, alpha-glycerophosphocholine, carnitine, adenosine 5′-triphosphate, or a combination thereof.

Подробнее
Номер записи: 4
04-06-2009 дата публикации

METHODS USING PHOSPHATIDYLSERINE, LYSOPHOSPHATIDYLSERINE, AND/OR SALTS THEREOF TO INCREASE TESTOSTERONE LEVELS

Номер: US20090143339A1
Автор: Martin Purpura, Ralf Jager, Scott L. Hagerman
Принадлежит:

Methods using phosphatidylserine, lysophosphatidylserine, and/or salts thereof to increase testosterone levels in subjects in need thereof are disclosed herein. The methods can be useful for subjects having age related decline in testosterone, exercise induced decline in testosterone, and/or hypogonadism.

Подробнее
Номер записи: 5
13-04-2023 дата публикации

PARAXANTHINE-BASED BIOACTIVE COMPOSITION AND METHOD OF USE THEREOF

Номер: US20230115966A1
Автор: Shawn Wells, Ralf Jager, Kylin Liao, Martin Purpura
Принадлежит:

The disclosed compositions, and methods relate to compositions for human consumption and comprising paraxanthine and a cholinergic agent and/or theanine. The disclosed compositions are useful promoting cognitive function, energy, athletic performance and providing neuroprotective anti-oxidative effects.

Подробнее
Номер записи: 6
25-11-2004 дата публикации

Utilization of phosphatidylserine in the treatment of attention deficit syndrome (adhs)

Номер: US20040235795A1
Автор: Ralf Jager, Dirk Bokenkamp
Принадлежит:

The invention concerns the use of phosphatidylserine (PS), lyso-phosphatidylserine or/and a physiologically acceptable salt thereof for the treatment of the attention deficit syndrome (ADHS) in small daily doses over a longer time period and in larger daily doses over a short period as well as in combination with suitable additives selected from the group comprising antioxidants, essential fatty acids, mineral substances, amino acids, mood-lifters or/and phospholipids. In this connection it is preferred to carry out the administration to probands aged 2 to 20 years preferably 3 to 10 years whereby the phosphatidylserine as well as the additives are used in solid and also in liquid formulations. Due to its positive properties phosphatidyl-serine is in particular suitable as a therapeutic agent or food supplement in connection with ADHS. The good tolerance of phosphatidylserine even in high doses and over a longer supplementation period and the excellent compliance should also be stressed ...

Подробнее
Номер записи: 7
08-01-2004 дата публикации

Choline pyruvate, method for the production thereof, formulations containing choline pyruvate and the use thereof

Номер: US20040006139A1
Автор: Ralf Jager, Martin Purpura, Gunter Ortenburger, Ivo Pischel
Принадлежит:

The invention relates to choline pyruvate of formula (I) wherein 0 Подробнее

Номер записи: 8
06-10-2005 дата публикации

Physiologically compatible, phospholipid-containing, stable and hard matrix

Номер: US20050220857A1
Автор: Martin Purpura, Dirk Cremer, Ralf Jager, Michaela Thalhammer
Принадлежит:

The invention concerns a physiologically compatible, phospholipid-containing, stable and hard matrix consisting of a supporting material and a bioactive component which has a total diameter of between 0.1 and 5000 μm and contains ≧5% by weight, based on the starting material, of acetone-insoluble components as the bioactive component, which are in particular phosphatidyl serine, phosphatidyl choline and such like, as well as lyso variants and/or derivatives thereof. This matrix which preferably has a supporting material consisting of carbohydrates and/or proteins and preferably additional bioactive substances as ingredients such as amino acids, vitamins, trace elements and similar substances, can have liquid contents and is used in particular in functional foods, special foods and dietary supplements.

Подробнее
Номер записи: 9
17-02-2005 дата публикации

Solid and stable creatine/citric acid composition(s) and compositions carbohydrate(s) or hydrates thereof, method for the production and use thereof

Номер: US20050037069A1
Автор: Martin Purpura, Ivo Pischel, Ralf Jager, Gunter Ortenburger
Принадлежит:

A description is given of formulations comprising solid and stable creatine/citric acid composition(s) and carbohydrate(s) or hydrates thereof having a weight ratio of the constituents creatine/citric acid composition(s) and carbohydrate(s) of 1:0.01 to 1.0. Carbohydrate components, which can be used in anhydrous form, as hydrates or as moist products, are in principle all polyhydroxyaldehydes and polyhydroxyketones. The creatine component is preferably used in anhydrous form or in aqueous alcoholic or organic solution. The formulations should preferably be prepared by reacting the carbohydrates in the form of solutions, suspensions or as solid substance with the creatine/citric acid composition or solution thereof at −20 to 120° C. and, if appropriate, finally removing the liquid phase, or else by a thermal treatment, a treatment with ultrasound or microwave of mixtures consisting of the creatine component and solid carbohydrates, preferably in a vacuum. This produces formulations comprising ...

Подробнее
Номер записи: 10
25-11-2004 дата публикации

Formulation containing (lyso-)phosphatidylserine for the prevention and treatment of stress states in warm blooded animals

Номер: US20040234544A1
Автор: Ralf Jager, Bokenkamp Dirk
Принадлежит:

The invention concerns a formulation containing phosphatidylserine (PS) and/or lyso-phosphatidylserine for preventing and treating mental and physical stress states, where the phosphatidylserine is, among others, combined with plant extracts or essences. Daily doses of 50 to 1000 mg PS are envisaged within the scope of the present invention which are administered over a maximum period of six months. Preferred subjects are humans of 10 to 50 years of age.

Подробнее
Номер записи: 11
23-03-2017 дата публикации

METHOD FOR INCREASING ABSORPTION OF PLANT DERIVED PROTEINS

Номер: US20170079311A1
Автор: Ralf Jager, Mark Olson, Joseph P. Mannion, Jaroslav Boublik, Martin Purpura, JAGER RALF, OLSON MARK, MANNION JOSEPH P, BOUBLIK JAROSLAV, PURPURA MARTIN, Jager Ralf, Olson Mark, Mannion Joseph P., Boublik Jaroslav, Purpura Martin
Принадлежит:

A method for improving the absorption of amino acids from protein sources include adding one or more carbohydrases to a protein source. Plant protein such as that found in rice may be extracted to provide a rice concentrate useful in regimens requiring elevated amounts of protein consumption. To improve the absorption of the amino acids found in rice inside the human gastrointestinal tract, a carbohydrases such as Alpha-galactidase is added to the protein source prior to ingestion. The composition may also include proteases.

Подробнее
Номер записи: 12
14-12-2006 дата публикации

Filler for a beverage container

Номер: US20060280843A1
Автор: Ralf Jager, Martin Purpura, Reinhard Kroner
Принадлежит:

The present invention comprises a filler material for a container having at least one compartment, which container is situated in a pressurized beverage container and, immediately after the beverage container is opened, is suitable for mixing the filling into the drinks liquid surrounding the container. The filling itself is in granule form of defined particle diameter and is composed, in particular, of the main component a) in the form of a food supplement and an effervescent component b). The component a) which should be present in the filling in amounts of between 35 and 98% by weight can also be pharmaceutical active ingredients, vitamins, creatine derivatives, phospholipids, probiotics, minerals, unsaturated fatty acids and any desired mixtures thereof. The fillings can be introduced into drinks liquids of varying pH, since, because of its solubility and due to the targeted selection of suitable effervescent and disintegrant components, can be rapidly and completely dissolved or suspended ...

Подробнее
Номер записи: 13
05-05-2005 дата публикации

Use of creatine pyruvate for increasing stamina during highly intensive intermittent physical exertion

Номер: US20050096392A1
Автор: Ralf Jager, Martin Purpura, Dirk Bokenkamp
Принадлежит:

The invention relates to the use of creatine pyruvate for increasing stamina during highly intensive intermittent physical exertion. Said use is to be applied in particular during short-term intensive muscular exertion and/or muscular exertion of short-duration and/or that is repeated in short intervals, preferably during sprinting and sporting performances in running disciplines and during exercises using sports equipment provided with rollers, wheels or sliding surfaces, in addition to during raising, pulling and/or lifting movements of the extremities and the neck. The invention relates in particular to variants, in which muscular exertion is maintained for between 0.1 seconds and 5 minutes and/or during which the muscular exertion is carried out with a frequency of between 0.1 and 600 minutes. In the latter variant, the muscular exertion can increase with each interval. The creatine pyruvate is administered in the required application in daily doses of between 500 mg and 30 g and in ...

Подробнее
Номер записи: 14
11-01-2007 дата публикации

Physiologically active composition based on phosphatidylserine

Номер: US20070009590A1
Автор: Martin Purpura, Ralf Jager, Roland Rabeler, Hans-Ullrich Hoppe
Принадлежит:

This physiologically active composition contains, as physiologically active constituents, the components a) phosphatidylserine and/or lysophosphatidylserine (in each case “PS”) and b) at least one (lyso)phospholipid different from component a) and c) a serine source different from component a), for example L-serine and/or O-phospho-L-serine. In this composition, the components a) and also b) and c) must each be present in a molar ratio a:b (where b Подробнее

Номер записи: 15
11-08-2005 дата публикации

Functional foods containing a phospholipid-containing stable matrix

Номер: US20050175763A1
Автор: Martin Purpura, Dirk Cremer, Ralf Jager, Michaela Thalhammer
Принадлежит: Degussa Bloactive GmbH

The claimed functional foods and specialized foods each contain a physiologically compatible phospholipid-containing stable matrix consisting of a supporting material and a bioactive component, the phospholipid component being in particular phosphatidyl serine, phosphatidyl choline and similar compounds, lyso variants and/or derivatives thereof. Liquid, solid and semiliquid forms of administration are preferred as the functional foods; food for tube feeding is regarded as preferred among the specialized foods. The matrix used for this should preferably have liquid contents and in particular have a diameter between 0.1 μm and 5.0 mm. It is also preferred when the matrix develops a delayed release after its ingestion with the respective foods which should preferably take place in the gastro-intestinal tract.

Подробнее
Номер записи: 16
16-02-2023 дата публикации

COMPOSITIONS AND METHODS TO INCREASE SERUM DILEUCINE LEVELS

Номер: US20230053297A1
Автор: Ralf Jager, Martin Purpura, Shawn D. Wells, Kylin Liao
Принадлежит:

Disclosed herein in is a method of increasing plasma dileucine levels in a subject comprising administering to the subject an effective amount of a composition comprising leucine. In certain embodiments, the composition does not comprise dileucine. In certain embodiments, the amount of increase in plasma dileucine is greater than that resulting from administering a protein supplement comprising a comparable amount of leucine. In certain implementations, administration of the composition results in an increase in plasma dileucine that is from about 10% to about 50% greater than from administering a protein supplement comprising a comparable amount of leucine.

Подробнее
Номер записи: 17
30-11-2017 дата публикации

STABILIZATION OF BETA-HYDROXYISOVALERIC ACID FORMULATIONS IN SOFT GEL CAPSULES

Номер: US20170340572A1
Автор: Martin Purpura, Ralf Jager, Jie Gu, Xiong Zheng, lingwei dai, Yaohua Zhang
Принадлежит:

The disclosed are shelf-stable beta-hydroxyisovaleric acid containing soft gel compositions and methods for making such compositions. In certain aspects, disclosed compositions comprise a plant-based capsule shell and a liquid formulation comprising beta-hydroxyisovaleric acid and at least one excipient, wherein the soft gel capsule is shelf-stable. In certain aspects, the excipient is selected from selected from choline salt, betaine, phosphatidylcholine, alpha-glycerophosphocholine, carnitine, adenosine 5′-triphosphate, or a combination thereof.

Подробнее
Номер записи: 18
22-04-2004 дата публикации

Creatine/citric acid compound, method for the production of the same and the use thereof

Номер: US20040077719A1
Автор: Ralf Jager, Martin Purpura, Gunter Ortenburger
Принадлежит:

The invention relates to addition and/or co-ordination compounds consisting of creatine and citric acid in the ratio of >1.0 to 3.0:1.0. Said compounds are characterised in that they have (KBr) bands in the IR spectrum, where ν=3425 (±5) cm−1 (s), 1624 (±5) cm−1 (m-s) and 1247 (±5) cm−1 (m). Said compounds, which preferably contain no organic solvent and are present in a solid, pulverulent form are produced in particular by a method, according to which, a1) creatine, containing a maximum content of 20 wt. % water, is reacted with citric acid or its salts at temperatures between 0 and 70° C., or a2) creatine and citric acid or its salts, containing a total water content of between 5 and 15 wt. %, are ground at temperatures between 0 and 70° C., or a3) creatine is reacted with citric acid or its salts, in the presence of a solvent at temperatures between 0 and 70° C. The corresponding solvent is then eliminated to a maximum residual content of 1.0 wt. %. The invention also relates to formulations ...

Подробнее
Номер записи: 19
30-10-2003 дата публикации

Composition for effecting serum cholesterol levels

Номер: US20030203854A1
Автор: Ivo Pischel, Herbert Fairow, Ralf Jager
Принадлежит:

A new composition for effecting serum cholesterol levels is claimed, said composition comprising a) at least a waxy acid with 23 to 50 carbon atoms or derivatives thereof and with serum cholesterol level reducing properties, and b) 0 to 99.99% by weight of at least a component with serum cholesterol level effecting properties, and c) 0 to 20% by weight of at least a pharmaceutically acceptable formulation aid. The efficacy of this composition can be enhanced by further incorporation of other cholesterol reducing agents, like lecithin, tocotrienol, saponins, fibers, long-chain waxy alcohols and niacin. The claimed composition combines the benefits of the single physiolocology active constituence together with the technology to increase the biovailability.

Подробнее
Номер записи: 20
04-06-2009 дата публикации

Physiologically active composition

Номер: US20090142425A1
Автор: Ralf Jager, Hans-Henning Wenk, Heike Tom Dieck, Hans Ullrich Hoppe, Roland Rabeler
Принадлежит:

A physiologically active composition is claimed which comprises effective amounts of at least one compound from the group 4-O-methyldavidigenin, 4′-O-methyldavidigenin, davidigenin, elemicin, isoelemicin, herniarin, demethoxycapillarisin, in particular 6-demethoxycapillarisin and/or 6-demethoxy-3′-methoxy-capillarisin, hispiludin and 9-hydroxy-10E, 12Z, 15Z-octadecatrienoic acid, and also glycosides thereof, in particular glucosides and/or rhamnoglucosides of 4-O-methyldavidigenin and/or 4′-O-methyldavidigenin, salts and derivatives.

Подробнее
Номер записи: 21
01-01-2009 дата публикации

Physiologically- Active Composition Based on Collagen

Номер: US20090005322A1
Автор: Martin Purpura, Ralf Jager, Karim Balan, Dietrich Paper
Принадлежит:

The present invention concerns a physiologically active composition which contains an enzymatically hydrolysed collagen as the active component I and at least one component of the non-vitamin type having anti-oxidative and/or anti-inflammatory properties as the active component II. Collagen of animal origin that is soluble in cold water comes into particular consideration as component I and a fermentation broth or a plant extract comes into particular consideration as component II. This composition which is designed in particular as a food supplement or functional food can be used to prevent inflammatory and/or degenerative symptoms in particular with a chronic course such as for example arthritis and arthroses or to successfully treat these symptoms. The claimed composition can be used above all by professional, leisure and recreational athletes who suffer in particular from strained joint functions.

Подробнее
Номер записи: 22